187 related articles for article (PubMed ID: 34879641)
1. Clinical Implications of the Mitotic Index as a Predictive Factor for Malignant Transformation of Atypical Meningiomas.
Kwon SM; Kim JH; Kim YH; Hong SH; Cho YH; Kim CJ; Nam SJ
J Korean Neurosurg Soc; 2022 Mar; 65(2):297-306. PubMed ID: 34879641
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for high-grade transformation in benign meningiomas.
Kwon SM; Kim JH; Yoo HJ; Kim YH; Hong SH; Cho YH; Kim CJ; Nam SJ
Clin Neurol Neurosurg; 2020 Aug; 195():105897. PubMed ID: 32505062
[TBL] [Abstract][Full Text] [Related]
3. Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas.
Kim D; Niemierko A; Hwang WL; Stemmer-Rachamimov AO; Curry WT; Barker FG; Martuza RL; Oh KS; Loeffler JS; Shih HA
J Neurosurg; 2018 Apr; 128(4):1123-1132. PubMed ID: 28621619
[TBL] [Abstract][Full Text] [Related]
4. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ
Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972
[TBL] [Abstract][Full Text] [Related]
5. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
Palma L; Celli P; Franco C; Cervoni L; Cantore G
J Neurosurg; 1997 May; 86(5):793-800. PubMed ID: 9126894
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma.
Bruna J; Brell M; Ferrer I; Gimenez-Bonafe P; Tortosa A
Neuropathology; 2007 Apr; 27(2):114-20. PubMed ID: 17494511
[TBL] [Abstract][Full Text] [Related]
7. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
Palma L; Celli P; Franco C; Cervoni L; Cantore G
Neurosurg Focus; 1997 Apr; 2(4):e3. PubMed ID: 15096007
[TBL] [Abstract][Full Text] [Related]
8. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
[TBL] [Abstract][Full Text] [Related]
9. Benign versus atypical meningiomas: risk factors predicting recurrence.
Nowak A; Dziedzic T; Krych P; Czernicki T; Kunert P; Marchel A
Neurol Neurochir Pol; 2015; 49(1):1-10. PubMed ID: 25666766
[TBL] [Abstract][Full Text] [Related]
10. De novo versus transformed atypical and anaplastic meningiomas: comparisons of clinical course, cytogenetics, cytokinetics, and outcome.
Krayenbühl N; Pravdenkova S; Al-Mefty O
Neurosurgery; 2007 Sep; 61(3):495-503; discussion 503-4. PubMed ID: 17881961
[TBL] [Abstract][Full Text] [Related]
11. The Influence of Adjuvant Radiotherapy in Atypical and Anaplastic Meningiomas: A Series of 88 Patients in a Single Institution.
Pisćević I; Villa A; Milićević M; Ilić R; Nikitović M; Cavallo LM; Grujičić D
World Neurosurg; 2015 Jun; 83(6):987-95. PubMed ID: 25769488
[TBL] [Abstract][Full Text] [Related]
12. Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance.
Maier H; Ofner D; Hittmair A; Kitz K; Budka H
J Neurosurg; 1992 Oct; 77(4):616-23. PubMed ID: 1527622
[TBL] [Abstract][Full Text] [Related]
13. Mitotic Index and Progression-Free Survival in Atypical Meningiomas.
Domingo RA; Tripathi S; Vivas-Buitrago T; Lu VM; Chaichana KL; Quiñones-Hinojosa A
World Neurosurg; 2020 Oct; 142():191-196. PubMed ID: 32615290
[TBL] [Abstract][Full Text] [Related]
14. Role of MR Morphology and Diffusion-Weighted Imaging in the Evaluation of Meningiomas: Radio-Pathologic Correlation.
Ranabhat K; Bishokarma S; Agrawal P; Shrestha P; Panth R; Ghimire RK
JNMA J Nepal Med Assoc; 2019; 57(215):37-44. PubMed ID: 31080244
[TBL] [Abstract][Full Text] [Related]
15. Alteration of FOXM1 expression and macrophage polarization in refractory meningiomas during long-term follow-up.
Takei J; Tanaka T; Teshigawara A; Tochigi S; Hasegawa Y; Murayama Y
Transl Cancer Res; 2021 Jan; 10(1):553-566. PubMed ID: 35116285
[TBL] [Abstract][Full Text] [Related]
16. MIB-1 (Ki-67) index and transforming growth factor-alpha (TGF alpha) immunoreactivity are significant prognostic predictors for meningiomas.
Hsu DW; Efird JT; Hedley-Whyte ET
Neuropathol Appl Neurobiol; 1998 Dec; 24(6):441-52. PubMed ID: 9888154
[TBL] [Abstract][Full Text] [Related]
17. Histopathological features to define atypical meningioma: What does really matter for prognosis?
Barresi V; Lionti S; Caliri S; Caffo M
Brain Tumor Pathol; 2018 Jul; 35(3):168-180. PubMed ID: 29671247
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas.
Devaprasath A; Chacko G
Neurol India; 2003 Sep; 51(3):336-40. PubMed ID: 14652433
[TBL] [Abstract][Full Text] [Related]
19. Brain invasion assessability in meningiomas is related to meningioma size and grade, and can be improved by extensive sampling of the surgically removed meningioma specimen.
Pizem J; Velnar T; Prestor B; Mlakar J; Popovic M
Clin Neuropathol; 2014; 33(5):354-63. PubMed ID: 25034703
[TBL] [Abstract][Full Text] [Related]
20. A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas.
Perry A; Banerjee R; Lohse CM; Kleinschmidt-DeMasters BK; Scheithauer BW
Brain Pathol; 2002 Apr; 12(2):183-90. PubMed ID: 11958372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
